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Objective: To evaluate the antioxidant and thioacetamide induced liver toxicity using
extracts of aerial parts of Balanites roxburghii (B. roxburghii).
Methods: The in-vitro antioxidant activity was estimated for different extracts on super-
oxide, hydroxyl and 1,1- diphenyl-2-picrylhydrazyl free radicals and the hepatoprotective
activity of the selected plant extracts was evaluated by using thioacetamide-induced liver
intoxication in rats model.
Results: There were no visible signs of toxicity, mortality and no behavioral changes
were observed for the selected plant extracts (hydroalcoholic, ethyl acetate and hexane) at
2000 mg/kg body weight. The plant extracts showed dose-dependent effectiveness in the
inhibition of free radicals generation and hepatoprotective nature. The hydroalcoholic
extract showed more scavenging activity as compared to other extracts with IC50 values
of (332.50 ± 1.30) mg, (302.00 ± 1.50) mg and (230.40 ± 1.10) mg on superoxide, hy-
droxyl and 1,1- diphenyl-2-picrylhydrazyl free radicals. Aerial parts of B. roxburghii at
three dose levels such as 125 mg/kg, 250 mg/kg and 500 mg/kg showed dose dependent
percentage protection as standard drugs and on enhancement activities of serum
biomarker enzymes (aspartate aminotransferase, alanine transaminase, alkaline phos-
phatase, total bilirubin and total protein) observed in thioacetamide-induced hepatotox-
icity. The hydroalcoholic extract showed signiﬁcant results at 500 mg/kg body weight as
compared to other extracts (P < 0.05) with 65.65%, 62.39%, 59.89%, 55.90% and
54.61% on aspartate aminotransferase, alanine transaminase, alkaline phosphatase, total
bilirubin and total protein levels.
Conclusions: It was observed that the B. roxburghii plant extracts are non-toxic and
have capacity to restore the physiological changes caused by the hepatotoxic compounds.1. Introduction
Liver is a very important organ in the body playing a vital
role in the metabolic functions. Over the last few decades, the
morbidity and mortality of different types of liver diseases have
increased around the world[1]. Liver diseases include alcoholic,
non-alcoholic, microorganisms, genetic variation (autoimmune)and ﬁnally drugs toxicity[2]. All these liver diseases affect
persons of all ages, especially people with ages from 40 to 60
years, and cause the alterations in the normal physiological
functions of the body[3]. The untreated liver diseases and long
term usage of medication sometimes cause side effects and
ﬁnally lead to death[4]. So, researches on liver diseases are
critically important in these days to bring the major toll of
liver diseases under control for human health.
Medicinal plants are used in the natural medicines such as
Chinese traditional medicine, Indian Ayurveda and Unani
medicine in middle east countries[5]. Many of the currently
available drugs are derived either directly or indirectly from
medicinal plants. In recent times, many plants have been used
for a wide spectrum of liver diseases so far to recovery
processes of the intoxicated livers[6]. But there are many
medicinal plants available to provide scientiﬁc evidence for
their biological activities which have been used in traditionalarticle under the CC BY-NC-ND license (http://
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diseases[7]. One of those medicinal plants is Balanites
roxburghii (B. roxburghii)[8].
B. roxburghii which is commonly known as hingot belongs to
the family Zygophyllaceae. It is commonly found in sandy plain
areas like Western Rajastan, West Bengal, Maharashtra and drier
parts of India [9]. Different parts of theB. roxburghii have been used
to treat different diseases in traditional medicine. For example, the
fruits are used in the treatment of whooping cough, skin diseases
and antifertility; leaves are used for the treatment of jaundice and
the bark is used for swelling in body organs and inﬂammation
and used to treat snake-bite and dog bite[9–12]. But there are few
scientiﬁc evidences regarding its biological activities. So, the
author selected the aerial parts of B. roxburghii to evaluate its
antioxidant activity on superoxide, hydroxyl and 1,1- diphenyl-
2-picrylhydrazyl (DPPH) free radicals and the hepatoprotective
activity against thioacetamide (TAA)-induced liver toxicity.
2. Materials and methods
2.1. Drug and chemicals
Chemicals used for the study were of analytical grade.
Silymarin, TAA and DPPH were purchased from Sigma
Chemicals, USA, Nitroblue tetrozolium was purchased from
Sisco Research Laboratories Pvt Ltd., Mumbai. Riboﬂavin was
purchased from Loba Chemie Pvt Ltd., Mumbai. The kits for the
assessment of different biochemical parameters like aspartate
aminotransferase (AST), alanine transaminase (ALT), alkaline
phosphatase (ALP), total bilirubin and total protein were pur-
chased from Span Diagnostics Ltd., Gujarat, India.
2.2. Plant material and preparation of extracts
The plant material was collected at Andhra Pradesh, India on
July, 2012. The authentication of the plant was done by Rtd.
Prof. M. Venkaih, Department of Botany, Andhra University,
Visakhapatnam. The plant material was dried under shade and
powdered for extraction separately using maceration process
with hexane, ethyl acetate and hydroalcoholic (ethanol 70%),
and the extracted solvents were concentrated to dryness under
vacuum using rotavapour.
2.3. In vitro antioxidant activity
In-vitro antioxidant activity was assessed by using the pre-
pared extract of B. roxburghii using dimethyl sulphoxide as the
vehicle on superoxide, hydroxyl and DPPH free radicals[13,14].
The percentage of inhibition and IC50 values were calculated.
2.3.1. Superoxide radical scavenging activity
The superoxide scavenging activity of the selected plant
extracts was evaluated as per standard methods[13]. It was by the
absorption of light at 560 nm induction of superoxide free
radical generation by riboﬂavin and corresponding reduction
by nitroblue tetrazolium.
2.3.2. Hydroxyl radical scavenging activity
The scavenging activity of selected plants extracts on hy-
droxyl radical was measured as per established methods[14]. It
was studied by the competition between deoxyribose and theextract's antioxidant molecules for hydroxyl radicals generated
from the Fe2+/ethylene diamine tetraacetic acid/H2O2 system.
2.3.3. DPPH radical scavenging activity
The DPPH radical scavenging activity was measured as per
methods[13,14]. This method is based on measure of color
absorbance of alcoholic DPPH solution (blue color) after
addition of antioxidant solution (extract/compound). If
antioxidants present in the test compound blue color due to
DPPH changes to yellow color.
2.3.4. Calculation of percentage inhibition
The percentage inhibition of the superoxide production by
the extract was calculated using the formula:
Inhibitory ratio = (A0 − A1) × 100/A0
where A0 was the absorbance of control and A1 refered to the
absorbance of plant extract or/and ascorbic acid.
2.3.5. IC50 calculation form percentage inhibition
The optical density obtained with each concentration of the
extract/ascorbic acid was plotted taking concentration on X-axis
and percentage inhibition on Y-axis. The graph was extrapolated
to ﬁnd the 50% inhibition concentration of extract/ascorbic acid.
2.4. Selection of animals
Healthy albino rats of either sex weighing between 180 and
250 g aging from 60 to 90 days were used for the study. The rats
were taken care of at standard light and humidity by supplying
proper food and water.
2.5. Acute toxicity studies
The acute toxicity study was conducted for B. roxburghii
extracts as per Organisation for Economic Co-operation and
Development (OECD) guidelines 420 (OECD. 2001) and reg-
ulations of the Institutional Animal Ethics Committee (No. 516/
01/A/CPCSEA).The albino mice of single sex were selected into
three groups (n = 6). They were maintained for one week before
the experiment under room temperature and allowed free access
to water and diet. The animals were subjected for acute toxicity
study using each extract at a dose of 2000 mg/kg orally in 2
groups at regular intervals of time, i.e., 1, 2, 4, 8, 12 and 24 h.
During this time, the animals were under observation to note
different conditions like skin changes, morbidity, aggressive-
ness, oral secretions, sensitivity to sound and pain, respiratory
movements and ﬁnally their mortality.
2.6. Assessment of hepatoprotective activity of
B. roxburghii
The selected plant extracts were tested for their hep-
atoprotective nature using TAA-induced liver toxicity in rats[15].
For this experiment, animals were grouped into twelve groups
(n = 6). Animals in group I were treated with normal saline
(vehicle) for one week through oral administration at 2 mL/kg
body weight. Rats in group II and group III were treated with
TAA as a 2% w/v solution in water on the ﬁrst day at 50 mg/
kg body weight subcutaneously, then group II was
Table 2
IC50 of different extracts of B. roxburghii against superoxide, hydroxyl
and DPPH radicals.
Name of the
extracts
IC50 (mg)
Superoxide
radical
Hydroxyl
radical
DPPH radical
Hydroalcoholic 332.50 ± 1.30 302.00 ± 1.50 230.40 ± 1.10
Ethyl acetate 356.00 ± 0.80 260.00 ± 1.20 359.50 ± 0.68
Hexane 486.00 ± 0.62 503.00 ± 0.76 507.80 ± 0.24
Ascorbic acid 54.40 ± 1.10 68.00 ± 1.30 22.00 ± 0.50
Hydroalcoholic extract
IC
50
 (μ
g)
700
600
500
400
300
200
100
0
Ethyl acetate extract
Hexane extract Ascorbic acid
Superoxide radical  Hydroxyl radical   DPPH radical
Figure 1. IC50 of different extracts of B. roxburghii against superoxide,
hydroxyl and DPPH radicals.
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dose of 25 mg/kg body weight orally for three weeks. Groups IV
to XII were treated with TAA as a 2% w/v solution in water on
the ﬁrst day at 50 mg/kg body weight subcutaneously, then
groups IV, V and VI were treated with the hydroalcoholic
extract, and groups VII, VIII, IX were treated with the ethyl
acetate extract and groups X, XI, XII were treated with the
hexane extract at a doses of 125, 250, 500 mg/kg body weight
orally for three weeks. Animals of all groups were
anaesthetized using chloroform after 48 h of ﬁnal dose
administration of extracts. The blood samples were collected
from animal groups by retro-orbital plexus, then samples were
centrifuged at 2400 r/min for quarters of an hour. After
centrifugation, clearly separated serum was used for measuring
the different biochemical parameters using autoanalyzer with
the help of reagent kits[16,17]. All the experimental procedures
involving animals were conducted according to OECD
guidelines and approved by the institutional animal ethics
committee, Andhra University.
3. Results
3.1. Antioxidant activity
In the present study, the tested extracts of B. roxburghii were
found to possess concentration dependent antioxidant activity on
superoxide, hydroxyl and DPPH free radicals.
Superoxide anion radical (O2
−) are formed by activated
phagocytes, such as monocytes, macrophages, eosinophils and
neutrophills, and the production of O2
− is an important factor in
the killing of bacteria by phagocytes. In the present method,
superoxide anion was derived from riboﬂavin and reduced by
nitroblue tetrazolium. The decrease in absorbance at 560 nm
with tested extracts/compounds indicated the utilization of su-
peroxide anion in the reaction mixtures. The mean IC50 values
on superoxide radical for hydroalcoholic, ethyl acetate and
hexane extracts of B. roxburghii were found to be
(332.50 ± 1.30) mg, (356.00 ± 0.80) mg and (486.00 ± 0.62) mg,
respectively. The mean IC50 value of ascorbic acid was found to
be (54.40 ± 1.10) mg. The hydroalcoholic extract at a concen-
tration of 640 mg showed the better scavenging activity on su-
peroxide free radical (Table 1, Table 2 and Figure 1).
Hydroxyl radical is the main reactive oxygen species (ROS)
with very short life span damaging every part of the living cell as
compared to other ROS. These molecules sometimes bind with
the nucleotides in the genetic materials of the body causing
cancers, mutations and toxicity. Hydroxyl radical scavenging
activity was measured by studying the competition between
deoxyribose and the extracts for hydroxyl radicals generated
from the Fe2+/ethylene diamine tetraacetic acid/H2O2 system
(Fenton reaction). The mean IC50 values on hydroxyl radical ofTable 1
Concentration dependent percentage inhibition of different extracts of B. rox
Name of the extracts C
20 40
Hydroalcoholic 8.50 ± 0.30 18.50 ± 1.00 30.4
Ethyl acetate 9.20 ± 0.50 18.60 ± 0.23 27.4
Hexane 7.24 ± 0.80 15.20 ± 0.60 24.8
Ascorbic acid 28.15 ± 0.50 43.19 ± 1.50 56.8hydroalcoholic, ethyl acetate and hexane extracts of
B. roxburghii were found to be (302.00 ± 1.50) mg,
(260.0 ± 1.20) mg and (503.0 ± 0.76) mg, respectively. The mean
IC50 value of ascorbic acid was found to be (68.00 ± 1.30) mg.
The hydroalcoholic extract had better antioxidant activity on
hydroxyl radical at 640 mg as compared to other extracts
(Tables 2 and 3, Figure 1).
DPPH is a stable free radical having the highest absorption at
517 nm. DPPH is easily stabilized by combining with the
electrons or hydrogen radicals. The antioxidants have the ability
of donating hydrogen. This makes the reduction of absorbance
by DPPH, because of its stabilization with hydrogen ions (re-
action mixtures' purple color changed into yellow color). So,
DPPH free radical scavenging activity is commonly used for the
identiﬁcation of antioxidant activity of different extracts/com-
pounds. The tested extracts (hydroalcoholic, ethyl acetate and
hexane) of B. roxburghii were found to be dose dependent
percentage of inhibition on DPPH free radical with IC50 values
of (230.40 ± 1.10) mg, (359.50 ± 0.68) mg and
(507.80 ± 0.24) mg, respectively. The hydroalcoholic extract
have more inhibition, i.e., (78.25 ± 1.80) mg, at 640 mg (Tables 2
and 4, Figure 1).burghii on superoxide radical.
oncentration (mg/0.1 mL)
80 160 320 640
0 ± 1.10 42.51 ± 1.20 56.15 ± 1.20 69.30 ± 0.50
5 ± 0.15 38.62 ± 0.34 48.18 ± 0.25 61.92 ± 0.35
0 ± 1.00 32.90 ± 0.30 44.25 ± 1.40 54.80 ± 0.50
7 ± 1.40 74.46 ± 0.70 80.72 ± 2.10 84.41 ± 1.20
Table 3
Concentration dependent percentage inhibition of different extracts of B. roxburghii on hydroxyl radical.
Name of the extracts Concentration (mg/0.1 mL)
20 40 80 160 320 640
Hydroalcoholic 8.40 ± 0.50 16.50 ± 1.10 25.40 ± 0.50 36.10 ± 1.20 51.30 ± 1.00 62.80 ± 1.10
Ethyl acetate 10.20 ± 0.30 21.58 ± 0.50 32.24 ± 0.30 43.60 ± 0.50 52.98 ± 0.50 66.46 ± 0.30
Hexane 7.28 ± 0.20 15.86 ± 0.24 23.48 ± 0.46 34.52 ± 0.32 45.42 ± 0.84 53.88 ± 0.72
Ascorbic acid 24.32 ± 1.00 35.12 ± 0.40 55.61 ± 1.10 65.31 ± 1.20 76.25 ± 1.20 82.11 ± 0.70
Table 4
Concentration dependent percentage inhibition of different extracts of B. roxburghii on DPPH radical.
Name of the extracts Concentration (mg/0.1 mL)
20 40 80 160 320 640
Hydroalcoholic 9.70 ± 0.40 15.80 ± 1.10 20.60 ± 0.50 32.70 ± 1.10 56.80 ± 1.20 78.25 ± 1.80
Ethyl acetate 8.58 ± 0.38 17.50 ± 0.14 22.68 ± 0.28 31.88 ± 0.62 48.28 ± 0.14 62.46 ± 1.22
Hexane 7.54 ± 0.13 16.36 ± 0.34 21.56 ± 0.82 29.58 ± 0.36 41.78 ± 1.20 54.62 ± 0.80
Ascorbic acid 48.00 ± 0.50 88.08 ± 1.00 90.68 ± 0.30 93.63 ± 0.50 94.21 ± 0.30 94.74 ± 1.10
SGOT enzyme level
0          50        100         150        200        250        300       350
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Figure 2. SGOT enzyme levels due to the effect of B. roxburghii extracts
at different doses on TAA-induced liver toxicity in rats.
Group XII 
Group XI
Group X
Group IX
Group VIII
Group VII
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There were no visible signs of toxicity, mortality and no
behavioral changes such as alertness, motor activity, breath-
lessness, restlessness, diarrhea, tremor, convulsion and coma
were observed at the administered doses. The animals were
physically active and no death was recorded even at the dose of
up to 2000 mg/kg body weight. Hence, all the tested extracts
were considered as safe and non-toxic.
3.3. Hepatoprotective activity
We examined the aerial parts of B. roxburghii at three dose
levels, 125 mg/kg, 250 mg/kg and 500 mg/kg, and assessed by
measuring liver-related biochemical parameters [serum
glutamic-oxaloacetic transaminase (SGOT), serum glutamic
pyruvic transaminase (SGPT), ALP, total serum bilirubin and
total protein] levels for their hepatoprotective nature using TAA-
induced hepatotoxicity in rats (Table 5 and Figures 2–6).Table 5
Percentage protection (%) of enzymes levels due to the effect of
B. roxburghii extracts at different doses on TAA-induced liver toxicity in
rats.
Extract of
B. roxburghii
Quantity
of the
extract
(mg/kg
body
weight)
Percentage protection on enzymes levels
of TAA-induced hepatotoxicity
SGOT
(IU/L)
SGPT
(IU/L)
ALP
(IU/
L)
Total
bilirubin
(mg/dL)
Total
protein
(g/dL)
Silymarin 50 96.24 95.25 93.90 97.83 96.14
Hydroalcoholic 125 37.70 35.33 37.24 23.42 24.97
250 51.85 49.43 47.86 36.24 37.48
500 65.65 62.39 59.89 55.90 54.61
Ethyl acetate 125 36.13 31.20 30.20 28.55 28.92
250 47.08 43.30 41.72 40.51 41.44
500 59.17 58.55 55.01 57.61 56.59
Hexane 125 32.86 29.91 26.12 22.56 22.33
250 44.10 40.88 38.30 35.38 34.85
500 56.76 54.27 52.49 52.48 50.66
0                        50                     100                      150                    200
SGPT enzyme level
Group VI
Group V
Group IV
Group III
Group II
Group I
Figure 3. SGPT enzyme levels due to the effect of B. roxburghii extracts at
different doses on TAA-induced liver toxicity in rats.
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Figure 4. ALP enzyme levels due to the effect of B. roxburghii extracts at
different doses on TAA-induced liver toxicity in rats.
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Figure 5. Total bilirubin enzyme levels due to the effect of B. roxburghii
extracts at different doses on TAA-induced liver toxicity in rats.
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Figure 6. Total protein enzyme levels due to the effect of B. roxburghii
extracts at different doses on TAA-induced liver toxicity in rats.
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the biomarkers of liver enzymes (AST (SGOT), ALT (SGPT),
ALP, total bilirubin and total protein) levels. Group II treated
TAA showed signiﬁcant changes in levels of biomarker enzymes.
The animals of group III were administered with TAA and then
silymarin. There were signiﬁcant changes in biomarker enzymes
levels as compared to group II and the percentage protection
offered by the silymarin against the changes in AST (SGOT),
ALT (SGPT), ALP, total bilirubin and total protein levels were
96.24%, 95.25%, 93.90%, 97.83% and 96.14%, respectively.
The percentage protection produced by the hydroalcoholic
extract (Groups IV, V and VI) on the enhancement of AST
(SGOT), ALT (SGPT), ALP, total bilirubin and total protein
levels were 37.70%, 35.33%, 37.24%, 23.42% and 24.97%,
51.85%, 49.43%, 47.86%and 36.24% and 37.48%, 65.65%,
62.39%, 59.89%, 55.90% and 54.61% at doses of 125, 250 and
500 mg/kg body weight, respectively.
The percentage protection produced by the ethyl acetate ex-
tracts (Groups VII, VIII and IX) of the enhancement of AST
(SGOT), ALT (SGPT), ALP, total bilirubin and total protein
levels were 36.13%, 31.20%, 30.20%, 28.55% and 28.92%,
47.08%, 43.30%, 41.72%, 40.51% and 41.44%, 59.17%,
58.55%, 55.01%, 57.61% and 56.59% at doses of 125, 250 and
500 mg/kg body weight, respectively.
The percentage protection produced by the hexane extracts
(Groups X, XI and XII) on the enhancement of AST (SGOT),
ALT (SGPT), ALP, total bilirubin and total protein levels were
32.86%, 29.91%, 26.12%, 22.56% and 22.33%, 44.10%,
40.88%, 38.30%, 35.38% and 34.85%, 56.76%, 54.27%,
52.49%, 52.48% and 50.66% at doses of 125, 250 and 500 mg/
kg body weight, respectively.
The decrease in the SGPT, SGOT, ALP and total bilirubin
levels, increase in levels of protein to normal and percentageprotection produced by the higher dose of the extracts were
comparably similar to silymarin. Among all extracts, hydro-
alcoholic extract of the selected plants showed a better activity.
4. Discussion
The liver participates in different physiological metabolisms
of the body, such as the exclusion of body wastage. So, the
protection of liver is very important for the human wealth.
However, in recent years, liver diseases are one of the most
severe diseases causing deaths around the world. Hepatotoxic
agents can react with the basic cellular components and conse-
quently induce acute liver failure[18]. TAA is a thiono-sulfur
containing compounds and has been used as a fungicide,
organic solvent. At the same time, it is hepatotoxic. TAA causes
centrilobular necrosis with a subsequent regenerative response
of liver leading to liver cirrhosis and hepatocarcinoma[19,20].
TAA induces the formation of reactive metabolites (free
radicals) derived from thioacetamide-S-oxide and by ROS
generated as intermediates, which leads to the cell death from
apoptosis and necrosis[16]. The metabolites produce are
covalently attached to the cellular macromolecules induce the
oxidative stress[17]. ROS production resulting from TAA
administration was followed by lipid peroxidation, glutathion
depletion and reduction in the SH-thiol groups and TAA also
affects the calcium movement from intracellular parts[21]. All
these effect the cellular permeability like different cell
organelles, mainly effect the function of mitochondria, power
house of the cell, by inhibiting the respiration[22].
The results of our experiment provide evidence for the hep-
atoprotective and antioxidant activities of B. roxburghii. The
elevated enzymes level after treating with the TAA were signiﬁ-
cantly restored by treating with 125, 250 and 500 mg/kg body
weight doses of B. roxburghii extracts in the different groups. The
results of percentage protection of the extracts are well comparable
with the standard drug, silymarin, and the tested extracts also
showed the signiﬁcant antioxidant activity on different free radi-
cals[16,21,22]. It could be concluded by the above results that
B. roxburghii plant extracts have the capacity in reduce the
formation of the ROS by TAA, cellular apoptosis, lipid
peroxidation by reducing the bonding of the radicals to
membarane proteins. All these conditions protect the liver cells
from the loss of cellular metabolites and maintain the normal
function of the mitochondria. The hydroalcoholic extract of
B. roxburghii showed more hepatoprotective and antioxidant
activities because of the lack of solubility of the bioactive
molecules in the other extracted solvents. The observed activities
may be due to the presence of different phytocompounds.
Further studies are needed to isolate and characterize the active
entities presenting in B. roxburghii extracts and complete the
explanation of their mechanism of action.
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